Who's Line Is It Anyway?'s long-running performer—was diagnosed with a detached retina, prompting him to seek emergency eye ...

OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, and a panel of experts examined a series of unusual ...

Having missed seven games in 2025 due to a neck injury that he reaggravated in a one-game return that led to surgery, ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

RenewaLift offers a modern, convenient solution that aims to help users improve the appearance of their neck and jawline at ...

The Toyota Tundra is one of the most popular model trucks in the world, but it's not perfect. If you're in the market, be ...

For generations, adults with amblyopia were told their vision loss was permanent, a childhood problem that medicine could not meaningfully reverse later in life. A new wave of research from MIT and ...

The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.

Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...

Jesy Nelson noticed worrying signs about her twin daughters’ Ocean Jade and Story Monroe’s health, weeks before they were ...

Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets –– Pivotal Phase 3 trials in ...